Optimal control analysis of HIV-TB co-infection model
From MaRDI portal
Publication:5016705
Recommendations
- A TB-HIV/AIDS coinfection model and optimal control treatment
- An optimal treatment control of TB-HIV coinfection
- Estimating the impact of antiretroviral therapy on HIV-TB co-infection: optimal strategy prediction
- Assessing the effects of Holling type-II treatment rate on HIV-TB co-infection
- scientific article; zbMATH DE number 7615974
Cites work
Cited in
(20)- Controlling Co-Epidemics: Analysis of HIV and Tuberculosis Infection Dynamics
- A TB-HIV/AIDS coinfection model and optimal control treatment
- A co-infection model on TB - COVID-19 with optimal control and sensitivity analysis
- Optimal control of intervention strategies in malaria–tuberculosis co-infection with relapse
- Analysis of an age-structured model for HIV-TB co-infection
- Assessing the effects of Holling type-II treatment rate on HIV-TB co-infection
- An optimal treatment control of TB-HIV coinfection
- Treatment and vertical transmission in a HIV-TB co-infection model
- Prevention strategy for superinfection mathematical model tuberculosis and HIV associated with AIDS
- Multiobjective optimization to a TB-HIV/AIDS coinfection optimal control problem
- HIV-TB co-infection treatment: modeling and optimal control theory perspectives
- A dynamical analysis and numerical simulation of COVID-19 and HIV/AIDS co-infection with intervention strategies
- Transmission model for the co-infection of HIV/AIDS and tuberculosis
- Optimal control of TB transmission based on an age structured HIV-TB co-infection model
- A co‐infection model for oncogenic human papillomavirus and tuberculosis with optimal control and Cost‐Effectiveness Analysis
- Optimal control strategies on HIV/AIDS and pneumonia co-infection with mathematical modelling approach
- Optimal control analysis of a COVID-19 and tuberculosis (TB) co-infection model with an imperfect vaccine for COVID-19
- scientific article; zbMATH DE number 7615974 (Why is no real title available?)
- Dynamics of tuberculosis in HIV–HCV co-infected cases
- Estimating the impact of antiretroviral therapy on HIV-TB co-infection: optimal strategy prediction
This page was built for publication: Optimal control analysis of HIV-TB co-infection model
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q5016705)